Zhiyi Biotech Successfully Completes Phase I Clinical Trial of SK10 for the Treatment of Chemotherapy-induced Diarrhea

GUANGZHOU, China, July 5, 2024 /PRNewswire/ — Zhiyi Biotech, a clinical-stage biotech leading in discovery and development of LBPs (live biotherapeutic products), today announced positive results from a Phase 1 clinical trial in U.S. of SK10. SK10 is an innovative heat-killed Bacteroides…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.